Positive interim results were announced by Singapore’s Covid vaccine candidate ARCT-021, developed by Arcturus Therapeutics in collaboration with scientists from the Duke-NUS Medical School in Singapore. Nice!
Photo credit: Pavel Danilyuk
Singapore’s Co-Developed Vaccine Candidate is in ‘Good Shape’ For Delivery in 2021
Kommentare